NFA
VNDA icon

Nationwide Fund Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History

Nationwide Fund Advisors’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-41,085
Closed -$735K – 2042
2017
Q3 		$735K Sell
41,085
-600
-1% -$10K ﹤0.01% 1974
2017
Q2 		$679K Buy
41,685
+6,238
+18% +$89.9K ﹤0.01% 2011
2017
Q1 		$496K Sell
35,447
-4,190
-11% -$59.7K ﹤0.01% 2159
2016
Q4 		$632K Sell
39,637
-1,543
-4% -$24.8K ﹤0.01% 2038
2016
Q3 		$685K Sell
41,180
-2,513
-6% -$33.8K ﹤0.01% 2003
2016
Q2 		$489K Buy
43,693
+17,523
+67% +$170K ﹤0.01% 2159
2016
Q1 		$219K Sell
26,170
-1,304
-5% -$10.7K ﹤0.01% 2496
2015
Q4 		$256K Buy
27,474
+456
+2% +$4.55K ﹤0.01% 2427
2015
Q3 		$305K Hold
27,018
– – ﹤0.01% 2364
2015
Q2 		$343K Buy
27,018
+226
+0.8% +$2.44K ﹤0.01% 2446
2015
Q1 		$249K Sell
26,792
-3,249
-11% -$36.7K ﹤0.01% 2584
2014
Q4 		$430K Buy
30,041
+3,643
+14% +$43.1K ﹤0.01% 2271
2014
Q3 		$274K Buy
26,398
+154
+0.6% +$2.02K ﹤0.01% 2539
2014
Q2 		$425K Buy
26,244
+619
+2% +$8.24K ﹤0.01% 2351
2014
Q1 		$416K Sell
25,625
-60,226
-70% -$856K ﹤0.01% 2139
2013
Q4 		$1.06M Sell
85,851
-66,811
-44% -$671K ﹤0.01% 1830
2013
Q3 		$1.68M Buy
152,662
+131,446
+620% +$1.4M 0.01% 1542
2013
Q2 		$171K Buy
+21,216
New +$143K ﹤0.01% 2557

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nationwide Fund Advisors's VNDA Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Vanda Pharmaceuticals (VNDA) in Q4 2017, closing a stake of 41,085 shares — an estimated $735K sold.

Nationwide Fund Advisors first reported a position in VNDA in Q2 2013 and held it in 18 quarters. The position peaked at $1.68M in Q3 2013. 125 funds tracked by Wall St. Rank hold VNDA as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Vanda Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 41,085 Vanda Pharmaceuticals shares in Q4 2017, an estimated $735K.
  • Nationwide Fund Advisors first reported a position in Vanda Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Vanda Pharmaceuticals position peaked at $1.68M in Q3 2013.
  • 125 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.